Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: CV Disease in Adolescents With Type 2 Diabetes
This ClinicalTrials.gov update notes a completed study evaluating cardiovascular disease outcomes in adolescents with type 2 diabetes.
-
FDA approval · 2012-08-01FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved METFORMIN HYDROCHLORIDE under an original generic application by Mylan Pharmaceuticals Inc. for the treatment of type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Effect of Flavanol-rich Cocoa on Peripheral and Cerebral Blood Flow in Type 2 Diabetes [NA]
A completed clinical trial evaluated the effect of flavanol-rich cocoa on peripheral and cerebral blood flow in adults with Type 2 diabetes.
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM) [Phase 4]
Phase 4 trial evaluating the effects of ranolazine on exercise duration in patients with chronic stable angina and coronary artery disease w…
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: Safety and Efficacy of Insulin Aspart in Type 2 Diabetes [Phase 4]
An update on a Phase 4 trial assessing the safety and efficacy of insulin aspart in adults with Type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02) [Phase 1]
A Phase 1 pharmacokinetics study of MK-0941 in participants with renal impairment was terminated, with results posted.
-
FDA approval · 2012-07-20FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for metformin hydrochloride, a generic form used to treat type 2 diabetes mellitus (an…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating linagliptin in elderly patients with type 2 diabetes has completed, and results were posted on 2012-07-18 detaili…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid [Phase 3]
A Phase 3 trial update examining the efficacy and safety of adding linagliptin to metformin in adults with type 2 diabetes, including metfor…
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study) [Phase 4]
A Phase 4 trial comparing insulin glargine (Lantus) with a sulfonylurea for beta-cell function in type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Complementary and Integrative Therapy for Diabetic Neuropathy
The clinical trial evaluating complementary and integrative therapies for type 2 diabetes mellitus-related diabetic neuropathy has completed…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects [Phase 2]
A Phase 2 study evaluating dextromethorphan and amantadine on glucose homeostasis in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Skin Samples of Diabetic Patients and Healthy Volunteers Collection [NA]
A clinical trial (NCT01349374) examining skin samples from people with Type 2 diabetes and healthy volunteers has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006) [Phase 1]
A Phase 1 trial of the investigational drug MK-0941-006 in adults with Type 2 Diabetes Mellitus on basal insulin has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg [Phase 1]
Phase 1 single-cohort, two-period pharmacokinetic study evaluating metformin alone and in combination with ranolazine (500 mg) in Type 2 Dia…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED) [Phase 1]
Phase 1 pharmacokinetic study of MK-0941 after multiple daily doses in subjects with Type 2 diabetes completed; results posted in 2012.
-
CLINICAL_TRIALS research · 2012-07-11Clinical Trial Update: Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine [Phase 1]
Phase 1 single-cohort, four-period pharmacokinetics study assessing metformin alone and in combination with ranolazine in Type 2 Diabetes Me…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Effect of Pioglitazone on Ambulatory Blood Pressure [Phase 3]
Phase 3 clinical trial evaluating the effect of pioglitazone on ambulatory blood pressure in patients with hypertension and type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers [Phase 1]
A Phase 1 study evaluating the effects of PF-05175157 in healthy volunteers has completed. The study lists Diabetes Mellitus, Type 2 as the …
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Metabolic Effects of Alcohol [NA]
This clinical trial update summarizes the completed study on the metabolic effects of alcohol in people with Type 2 Diabetes Mellitus.
-
FDA approval · 2012-07-09FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment [Phase 4]
Phase 4 trial comparing the blood sugar-lowering effects of Biphasic Insulin Aspart 30 and Insulin Glargine, both used with metformin and gl…
-
CLINICAL_TRIALS research · 2012-07-06Clinical Trial Update: Evaluation of SCOUT DS Device in the Diagnosis of Diabetes
This document provides an update on a clinical trial evaluating the SCOUT DS device for diagnosing diabetes; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) [Phase 3]
A Phase 3 study (DURATION-3) evaluated adding exenatide weekly and once-daily insulin glargine to metformin (± sulfonylurea) in adults with …
-
EMA withdrawal · 2012-07-03EMA Application withdrawn: Pioglitazone Teva Generics (pioglitazone hydrochloride) — Teva Pharma B.V.
The EMA withdrew the application for pioglitazone hydrochloride generic by Teva Pharma B.V. (Pioglitazone Teva Generics) for Type 2 diabetes…